CAR T-cell therapyB7-H3-directed CAR T-cell therapyResiquimodPOx-RmedulloblastomaG3MB
…G3MB) is the most aggressive medulloblastoma subgroup. Although CAR T-cell therapy is promising, it has shown limited efficacy in G3MB due to poor…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 781–840 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
reperfusion treatment2smoking cessation treatment2standard physiotherapy2stereotactic ablative radiotherapy2systemic anti-cancer therapy2targeted antimicrobial therapy2thrombolytics2transurethral resection2AC2ASCT2AT2AVT-treated2Ablative treatment2Adoptive T-cell therapy2Anti-vascular endothelial growth factor therapy2Antiseizure therapy2Autologous hematopoietic stem cell transplantation2BCG vaccination2Balloon pulmonary angioplasty2Breast-conserving surgery2CPAP treatment2CPR2CS therapy2Cardioneuroablation2Cardiopulmonary bypass2Cell-based therapies2Cellular immunotherapies2Cerebral embolic protection2Chelation therapy2Chimeric antigen receptor (CAR) T-cell therapies2Chimeric antigen receptor T cell (CAR-T) therapy2Circumcision2Complete surgical resection2Conservative therapy2Conventional therapies2Cytoreductive surgery2Direct current cardioversion2Dual anti-platelet therapy2Duodenal mucosal ablation2ETV2Emergency medicine2Emergency surgery2En bloc resection2Endoscopic Sleeve Gastroplasty2Endoscopic dilation2Endoscopic sinus surgery2Endoscopic third ventriculostomy2Erector spinae plane (ESP) block2External fixation2FD-based therapy2FOLFIRI2FOLFOX2Faecal immunochemical testing2Fluid therapy2Foramen Magnum Decompression2Gamma Knife radiosurgery2Guideline-directed heart failure therapy2Gut-directed hypnotherapy2Helicobacter pylori Treatment2Helicobacter pylori eradication2
Articles mentioning treatments
7,227 articles · page 130 of 603RPT177Lu-PSMA-617metastatic castration-resistant prostate cancermetastatic castration-resistant prostate cancer (mCRPC)mCRPCcyclophosphamideCyNCT03873805
…stry were monitored to evaluate the efficacy and safety.Results RPT and Cy treatment alter the endogenous immune landscape in the m…
IL-12 GEMy therapyCy/FluOsteosarcomacyclophosphamiderhabdomyosarcomafludarabineNational Institutes of Health
…stasis, making it an important disease for continued studies of IL-12 GEMy therapy.Methods F42010 murine syngeneic osteosarcoma cells were orthoto…
stem cell treatmentsadoptive cell therapiesadoptive cell therapycancerantibody therapies
… drugs such as antibody therapies, adoptive cell therapies, and stem cell treatments. Understanding complex biological systems requires extensive te…
tdRT_SLNAdoptive cell therapyUniversity of California San DiegoHead and neck squamous cell carcinoma (HNSCC)Gleiberman Head and Neck Cancer CentertdRTHNSCC
…RT_SLN mice remained tumor-free for the entirety of experiment. tdRT_SLN also showed highest survival ( figure 1B-C). Data was analyzed …
E7 TCR-T cell therapyT cell receptor (TCR)-T cell therapymelanomasynovial cell sarcomasynovial sarcomahuman papillomavirus (HPV)-associated cancersNIH IRB
…vardict and strelka.Results Patient 4 had primary resistance to E7 TCR-T cell therapy due to a nonsense mutation at amino acid position 51 in the α1 …
neoadjuvant immunochemotherapyNSCLC
…e II, IIIA, and IIIB (N2) NSCLC (AJCC 8th edition) treated with neoadjuvant immunochemotherapy, with or without adjuvant therapy. Baseline characteristics, tr…
chemotherapystereotactic body radiotherapyNivolumabBiliary tract canceripilimumabPembrolizumabgemcitabineGranzyme Bcisplatin
… with chemotherapy as first-line therapy for BTC is superior to chemotherapy alone, most patients still do not benefit from treatment.2 This…
platinum chemotherapyplatinum-doublet chemotherapyanti-PD-(L)1 therapymNSCLCdocetaxelpembrolizumabvibo/pembrovibostolimab
…axel in mNSCLC previously treated with anti-PD-(L)1 therapy and platinum chemotherapy. No significant difference in PFS was observed between vibo/pem…
lymphodepleting chemotherapyLDCLEU011solid tumorssolid tumoursLEU01101ClinicalTrials.govNorth East - York Research Ethics Committee
… linear CAR. The trial hypothesis is that LEU011, combined with lymphodepleting chemotherapy (LDC), will be safe and tolerable, and will elicit efficacy in …
RPT[67Cu]Cu-LLP2Aneuroblastomasolid tumors[ 67Cu]Cu-LLP2A67Cu]Cu-LLP2Ahematological malignanciesSK-N-ASNIH institutional IACUCNB
…he tumors in both SK-N-AS and IMR-5.Conclusions [ 67Cu]Cu-LLP2A RPT improves CAR T-cell efficacy by direct tumoricidal effects and …